9,9,10,10-Tetrafluoro-9,10-dihydrophenanthrene hepatitis C virus inhibitor and application thereof

Number of patents in Portfolio can not be more than 2000

United States of America Patent

PATENT NO 9512108
APP PUB NO 20160297804A1
SERIAL NO

15030990

Stats

ATTORNEY / AGENT: (SPONSORED)

Importance

Loading Importance Indicators... loading....

Abstract

See full text

The present invention belongs to the field of chemical pharmaceuticals, and specifically relates to compounds represented by formula I having a 9,9,10,10-tetrafluoro-9,10-dihydrophenanthrene structure and being able to inhibit hepatitis C virus activity, or a pharmaceutically acceptable salt, isomer, solvate, crystal or prodrug of said compounds, a pharmaceutical composition containing said compounds, and an application of said compounds or composition in the preparation of a drug. The compounds of the present invention have a good HCV inhibitory effect.

Loading the Abstract Image... loading....

First Claim

See full text

Family

Loading Family data... loading....

Patent Owner(s)

Patent OwnerAddress
NANJING SANHOME PHARMACEUTICAL CO LTDJIANGSU 210038

International Classification(s)

Inventor(s)

Inventor Name Address # of filed Patents Total Citations
Chen, Hongyan Nanjing, CN 12 7
Wang, Dezhong Nanjing, CN 2 2
Wang, Yong Nanjing, CN 1107 9670
Zhang, Cang Nanjing, CN 10 7
Zhang, Di Nanjing, CN 272 1341
Zhang, Xian Nanjing, CN 82 192
Zhao, Liwen Nanjing, CN 17 24
Zhou, Haiping Nanjing, CN 9 57

Cited Art Landscape

Load Citation

Patent Citation Ranking

Forward Cite Landscape

Load Citation

Maintenance Fees

Fee Large entity fee small entity fee micro entity fee due date
11.5 Year Payment $7400.00 $3700.00 $1850.00 Jun 6, 2028
Fee Large entity fee small entity fee micro entity fee
Surcharge - 11.5 year - Late payment within 6 months $160.00 $80.00 $40.00
Surcharge after expiration - Late payment is unavoidable $700.00 $350.00 $175.00
Surcharge after expiration - Late payment is unintentional $1,640.00 $820.00 $410.00